Table 4

Mean pharmacokinetic parameters for serum asparaginase activity

ParameterGroup A (n = 26)Group B (n = 28)
% coefficient of variation% coefficient of variation
V/F (liters/m212.8 55 8.3 50 
ka (h−10.149 62 *  
ke (h−10.031 35 0.055 17 
CL/F (L/h/m20.40 53 0.46 49 
t1/2,z (h) 22.1 35 12.6 17 
tmax (h) 14.0 38 18.4 17 
Amax (IU/mL) 1.25 57 1.10 49 
ParameterGroup A (n = 26)Group B (n = 28)
% coefficient of variation% coefficient of variation
V/F (liters/m212.8 55 8.3 50 
ka (h−10.149 62 *  
ke (h−10.031 35 0.055 17 
CL/F (L/h/m20.40 53 0.46 49 
t1/2,z (h) 22.1 35 12.6 17 
tmax (h) 14.0 38 18.4 17 
Amax (IU/mL) 1.25 57 1.10 49 

Amax, maximum serum enzyme activity; CL/F, apparent extravascular clearance of enzyme activity; t1/2,z, apparent biological half-life of enzyme activity; tmax, time of maximum serum enzyme activity.

*

For group B, ka = ke = k.

Predicted values for the initial dose of the drug.

Close Modal

or Create an Account

Close Modal
Close Modal